| Product Code: ETC9970948 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Multiomics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Multiomics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Multiomics Market - Industry Life Cycle |
3.4 United States (US) Multiomics Market - Porter's Five Forces |
3.5 United States (US) Multiomics Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 United States (US) Multiomics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United States (US) Multiomics Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.8 United States (US) Multiomics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United States (US) Multiomics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United States (US) Multiomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine |
4.2.2 Rising prevalence of chronic diseases |
4.2.3 Technological advancements in multiomics research |
4.3 Market Restraints |
4.3.1 High costs associated with multiomics analysis |
4.3.2 Lack of skilled professionals in multiomics research |
5 United States (US) Multiomics Market Trends |
6 United States (US) Multiomics Market, By Types |
6.1 United States (US) Multiomics Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Multiomics Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 United States (US) Multiomics Market Revenues & Volume, By Products, 2021- 2031F |
6.1.4 United States (US) Multiomics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) Multiomics Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.6 United States (US) Multiomics Market Revenues & Volume, By Software, 2021- 2031F |
6.1.7 United States (US) Multiomics Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Multiomics Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Multiomics Market Revenues & Volume, By Single-cell Multiomics, 2021- 2031F |
6.2.3 United States (US) Multiomics Market Revenues & Volume, By Bulk Multiomics, 2021- 2031F |
6.3 United States (US) Multiomics Market, By Platform |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Multiomics Market Revenues & Volume, By Genomics, 2021- 2031F |
6.3.3 United States (US) Multiomics Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.3.4 United States (US) Multiomics Market Revenues & Volume, By Proteomics, 2021- 2031F |
6.3.5 United States (US) Multiomics Market Revenues & Volume, By Metabolomics, 2021- 2031F |
6.3.6 United States (US) Multiomics Market Revenues & Volume, By Integrated Omics Platforms, 2021- 2031F |
6.4 United States (US) Multiomics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Multiomics Market Revenues & Volume, By Cell Biology, 2021- 2031F |
6.4.3 United States (US) Multiomics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.4 United States (US) Multiomics Market Revenues & Volume, By Neurology, 2021- 2031F |
6.4.5 United States (US) Multiomics Market Revenues & Volume, By Immunology, 2021- 2031F |
6.5 United States (US) Multiomics Market, By End use |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Multiomics Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.5.3 United States (US) Multiomics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.5.4 United States (US) Multiomics Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Multiomics Market Import-Export Trade Statistics |
7.1 United States (US) Multiomics Market Export to Major Countries |
7.2 United States (US) Multiomics Market Imports from Major Countries |
8 United States (US) Multiomics Market Key Performance Indicators |
8.1 Adoption rate of multiomics technologies in healthcare institutions |
8.2 Number of research publications utilizing multiomics approaches |
8.3 Funding and grants allocated to multiomics research |
9 United States (US) Multiomics Market - Opportunity Assessment |
9.1 United States (US) Multiomics Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 United States (US) Multiomics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United States (US) Multiomics Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.4 United States (US) Multiomics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United States (US) Multiomics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United States (US) Multiomics Market - Competitive Landscape |
10.1 United States (US) Multiomics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Multiomics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here